Robert W. Baird initiated coverage on Praxis Precision Medicines with a new price target

5/1/24 6:28:58 AM ET

Biotechnology: Pharmaceutical Preparations

Health Care

Robert W. Baird initiated coverage of Praxis Precision Medicines with a rating of Outperform and set a new price target of $117.00

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$PRAX

Date	Price Target	Rating	Analyst
6/2/2025	$97.00	Outperform	Oppenheimer
5/7/2025	$80.00	Buy	Chardan Capital Markets
3/3/2025	$120.00 → $105.00	Buy	H.C. Wainwright
2/11/2025	$111.00	Buy	Deutsche Bank
8/5/2024	$134.00	Outperform	Oppenheimer
6/24/2024	$145.00	Buy	Needham
6/18/2024	$155.00	Buy	Guggenheim
5/1/2024	$117.00	Outperform	Robert W. Baird